FIELD: organic chemistry, biochemistry, pharmacy. SUBSTANCE: invention relates to compounds of the formula (I) or the formula (II) where R1 means N(R10)(R11); R2 means lower thioalkyl; each of R3 and R5 means independently CH2 or C(O); R4 means unsubstituted or substituted lower thioalkyl where CH2NHC(O)R13 is a substituent and it is linked to the indicated thio-group; R6 means a residue of heteroaromatic α-amino acid; R7 means a residue of natural or synthetic α-amino acids; R8 means OH or lower alkoxy-group or in common with R7 it forms homoserine lactone; R9 means H; each of R10 and R11 represents independently H; R12 means unsubstituted or substituted fragment taken among aryl, aryl-lower alkyl where one or some lower alkyls or halogen atom are substituents; R13 means lower alkyl; R18 means H under condition that if R4 means unsubstituted lower thioalkyl then free thio-groups from R2 and R4 can form disulfide bond; or its pharmaceutically acceptable salts. Compounds elicit ability to inhibit activity of prenyltransferases. Invention describes also pharmaceutical compositions comprising indicated compounds and method of inhibition of activity of prenyltransferase. EFFECT: valuable biochemical properties of compounds. 22 cl, 3 ex
Authors
Dates
2003-04-10—Published
1997-05-29—Filed